Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1692234 Seattle, WA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$26,181,059
+$17,739,075 QoQ
Shares Held
784,099
+94.6% QoQ
Ownership
0.795%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 311 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. RARE ranks #14 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in RARE

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,181,059 784,099
2026-03-31 $8,441,984 402,959
2025-12-31 $19,338,860 840,820
2025-09-30 $25,280,762 840,451
2025-06-30 $4,370,286 120,195
2025-03-31 $3,759,393 103,822
2024-12-31 $2,910,694 69,187
2024-09-30 $4,922,339 88,611
2024-06-30 $6,413,775 156,053
2024-03-31 $7,617,050 163,141
2023-12-31 $9,593,406 200,615
2023-09-30 $6,555,570 183,887
2023-06-30 $7,848,417 170,137
2023-03-31 $7,307,701 182,237
2022-12-31 $5,079,712 109,642
2022-09-30 $3,866,657 93,375
2022-03-31 $242,913 3,345
2021-09-30 $225,655 2,502
2021-06-30 $1,774,271 18,608
2021-03-31 $3,649,667 32,054
2020-12-31 $5,470,751 39,520
2020-09-30 $3,343,898 40,685
2020-06-30 $2,651,187 33,894
2020-03-31 $2,154,276 48,487